AAAAAA

   
Results: 1-10 |
Results: 10
Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis
Authors: Espinosa, G Tassies, D Font, J Munoz-Rodriguez, FJ Cervera, R Ordinas, A Reverter, JC Ingelmo, M
Citation: G. Espinosa et al., Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis, SEM ARTH RH, 31(1), 2001, pp. 12-20
Budd-Chiari syndrome secondary to antiphospholipid syndrome - Clinical andimmunologic characteristics of 43 patients
Authors: Espinosa, G Font, J Garcia-Pagan, JC Tassies, D Reverter, JC Gaig, C Cervantes, F Cervera, R Bosch, J Ingelmo, M
Citation: G. Espinosa et al., Budd-Chiari syndrome secondary to antiphospholipid syndrome - Clinical andimmunologic characteristics of 43 patients, MEDICINE, 80(6), 2001, pp. 345-354
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome
Authors: Munoz-Rodriguez, FJ Reverter, JC Font, J Tassies, D Cervera, R Espinosa, G Carmona, F Balasch, J Ordinas, A Ingelmo, M
Citation: Fj. Munoz-rodriguez et al., Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome, HAEMATOLOG, 85(6), 2000, pp. 632-637
The 4G/5G polymorphism of the type 1 plasminogen activator-inhibitor gene and thrombosis in patients with antiphospholipid syndrome
Authors: Tassies, D Espinosa, G Munoz-Rodriguez, FJ Freire, C Cervera, R Monteagudo, J Maragall, S Escolar, G Ingelmo, M Ordinas, A Font, J Reverter, JC
Citation: D. Tassies et al., The 4G/5G polymorphism of the type 1 plasminogen activator-inhibitor gene and thrombosis in patients with antiphospholipid syndrome, ARTH RHEUM, 43(10), 2000, pp. 2349-2358
Mechanism of thrombosis in the antiphospholipid syndrome: Binding to platelets
Authors: Reverter, JC Tassies, D
Citation: Jc. Reverter et D. Tassies, Mechanism of thrombosis in the antiphospholipid syndrome: Binding to platelets, HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, 2000, pp. 290-298
Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs
Authors: Tassies, D Magallon, M Quintana, M Fernandez-Urgelles, M Rodriguez-Pinto, C Tusell, J Altisent, C Reverter, JC Mazzara, R Ordinas, A Monteagudo, J
Citation: D. Tassies et al., Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs, HAEMATOLOG, 84(10), 1999, pp. 930-936
Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome)
Authors: Balasch, J Reverter, JC Creus, M Tassies, D Fabregues, F Carmona, F Font, J Vanrell, JA
Citation: J. Balasch et al., Human reproductive failure is not a clinical feature associated with beta(2) glycoprotein-I antibodies in anticardiolipin and lupus anticoagulant seronegative patients (the antiphospholipid/cofactor syndrome), HUM REPR, 14(8), 1999, pp. 1956-1959
Erythropoietin: platelets and endothelium
Authors: Cases, A Diaz-Ricart, M Reverter, JC Tassies, D Escolar, G
Citation: A. Cases et al., Erythropoietin: platelets and endothelium, NEFROLOGIA, 19, 1999, pp. 12-16
Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome
Authors: Munoz-Rodriguez, FJ Tassies, D Font, J Reverter, JC Cervera, R Sanchez-Tapias, JM Mazzara, R Ordinas, A Ingelmo, M
Citation: Fj. Munoz-rodriguez et al., Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome, J HEPATOL, 30(5), 1999, pp. 770-773
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome
Authors: Munoz-Rodriguez, FJ Font, J Cervera, R Reverter, JC Tassies, D Espinosa, G Lopez-Soto, A Carmona, F Balasch, J Ordinas, A Ingelmo, M
Citation: Fj. Munoz-rodriguez et al., Clinical study and follow-up of 100 patients with the antiphospholipid syndrome, SEM ARTH RH, 29(3), 1999, pp. 182-190
Risultati: 1-10 |